Shengmai San

ISBN-13: 9780415284905 / Angielski / Twarda / 2002 / 160 str.

Robert Kam-Ming Ko

Opis

Traditional Chinese medicine commonly prescribes herbal formulas for the prevention and treatment of diseases. Shengmai San, a famous Chinese medicinal formula that has been used for more than eight hundred years in China, is comprised of Radix Ginseng, Fructus Schisandre and Radix Ophiopogonis. Traditionally, Shengmai San is used for the treatment of excessive loss of essence Qi and body fluid that threaten heart failure, particularly in the summer when heat exhaustion and profuse sweating commonly occur.
This book provides a comprehensive treatise on the historical, phytochemical, pharmacological/toxicological, clinical as well as pharmaceutical aspects of Shengmai San and its component herbs.

This book provides a comprehensive treatise on the historical, phytochemical, pharmacological/toxicological, clinical, and pharmaceutical aspects of Shengmai San and its component herbs. In traditional Chinese medicine, Shengmai San, which can restore blood volume and prevent myocardial infraction, is prescribed for patients with coronary heart disease and various cardiovascular disorders. Exploring the scientific rationale for using this multi-component formulation in traditional Chinese medicine for the prevention and treatment of diseases, the book includes pharmacological studies, case studies, side effects, contemporary applications, and more.

Spis treści

1. Shengmai San - A Renowned Traditional Chinese Medicine 2. Pharmacological Studies on Shengmai San 3. Clinical Studies on Shengmai San 4. Side Effects of Shengmai San 5. Phytochemistry and Pharmacology of Component Herbs of Shengmai San 6. Contemporary Applications of a Traditional Formula: Manufacturing of Shengmai San (SMS) Preparations and their Applications Duncan H.F. Mak, Hong Kong University of Science and Technology, Jie Chen, Shanghai Second Medical University, China, Kam-Ming Ko, Hong Kong University of Science and Technology, Liang-Yuan Zheng, Livzon Pharmaceutical Group, China, Mei-Hua Zhao, Shanghai Second Medical University, China, Shang-Biao Lu, Shanghai Second Medical University, China, Shu-Ying Chen, Guangzhou University of Traditional Medicine, China, Si-Qian Liang, Guangzhou University of Traditional Medicine, China, Siu-Po Ip, The Chinese University of Hong Kong, Song-Ming Liang, Guangzhou University of Traditional Medicine, China, Timothy C.M. Tam, The Chinese University of Hong Kong, Tze-Kin Yim, Hong Kong University of Science & Technology, Xiang-Yang Zhu, Shanghai Second Medical University, China, Ya-Chen Zhang, Shanghai Second Medical University, China, Ye-Zhi Rong, Shanghai Second Medical University, China, Yong-Qing Yan, The China Pharmaceutical University, Yun-Cheung Kong, The Chinese University of Hong Kong, Zhi-Min Xu, Shanghai Second Medical University, China

O autorze

Ko, Robert Kam-Ming